Armenian Doctors Optimistic On Battling AIDS

Key points
- Armenian doctors are sure that the modern-day plague can be beaten as hundreds of patients suffering from AIDS have already undergone treatment at a Yerevan clinic and feel well, Russia's RIA Novosti news agency reported.
- "Three hundred patients from 17 countries have received treatment at the Armenicum clinic in Yerevan and none of them has had any complaints.
- The Armenicum project, named after the medication of the same name, was launched by a team headed by Dr.
- Gevorkyan and his colleagues aimed to design a powerful stimulator to one's immune system, as well as a drug capable of fighting viral and bacterial infections.
Armenian doctors are sure that the modern-day plague can be beaten as hundreds of patients suffering from AIDS have already undergone treatment at a Yerevan clinic and feel well, Russia's RIA Novosti news agency reported.
"Three hundred patients from 17 countries have received treatment at the Armenicum clinic in Yerevan and none of them has had any complaints. All are alive," David Aslanyan, the spokesman for the clinic told the agency.
The Armenicum project, named after the medication of the same name, was launched by a team headed by Dr. Levon Gevorkyan, an honorary doctor of the Armenian National Academy of Sciences.
Gevorkyan and his colleagues aimed to design a powerful stimulator to one's immune system, as well as a drug capable of fighting viral and bacterial infections.
The key components of Armenicum are iodine, high and low molecular weight carbohydrates (polysaccharides), and lithium.
The inventors of Armenicum are still reluctant to disclose the secret behind the medicine, saying they fear their competitors may steal the technology before the drug is officially tested, certified and patented for marketing and sale throughout the world.
"The triumphant breakthrough of Armenicum is being stalled by the sharks of the international medication business who do not want to abandon enormous revenues - each year around $600 billion is spent on treating patients who suffer from AIDS," added Aslanyan.
The spokesman said, however, that the clinic was in negotiations with representatives of several foreign countries interested in certifying Armenicum abroad.
A course of therapy comprises three weeklong stages, with the total price of full treatment slightly exceeding $1,000. That figure is rather cheap if compared with prices for treatment of HIV-infected patients abroad, but the necessity to travel thousands of miles to the tiny Transcaucasian state in order to receive medication makes many patients think twice.
Armenicum has been officially registered with the Armenian Health Ministry and allowed for use in Armenian hospitals.
The medical center opened in December 1999 and three months later first patients checked in. Armenian doctors have been approached by their colleagues from Russia, Ukraine, Georgia and some other ex-Soviet republics seeking to test the medication and perhaps register it with their respective health ministries for use on their territories.
While the Armenian inventors are dithering and contemplating their business moves, other researchers interpret their reluctance to certify the product as a sign of absence of the properties Armenicum is said to possess.
One of the most vocal critics, head of the Russian Center for Preventing and Fighting AIDS, Dr. Vadim Pokrovsky had earlier said in a newspaper interview with Komsomolskaya Pravda that the refusal to have Armenicum tested outside Armenia revealed the aim of its inventors to earn easy money by attracting desperate patients to Armenia.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsHIV - Geneticists map human resistance to AIDS
Do our genes hold the key to future AIDS therapies? Using a supercomputer, scientists analyzed the genomes of thousands of strains of the HIV virus and have produced the first map of human AIDS resistance The key to…
29 October 2013
NewsTo halt AIDS, stop brief risk counseling, concentrate on testing, national study says
For decades, people seeking an HIV test have been counseled on realistic and achievable steps they could take to avoid infection. But a national study led by Miller School investigators has determined that, given the…
24 October 2013
NewsAIDSVu releases new maps that depict impact of HIV in America
The Rollins School of Public Health at Emory University launched its annual update of AIDSVu on National HIV Testing Day yesterday, including new interactive online maps that show the latest HIV prevalence data for 20…



